Browsing Centre for Cardiovascular Medicine and Devices by Issue Date

Identification of plasma protein biomarkers associated with idiopathic pulmonary arterial hypertension.

Abdul-Salam, VB; Paul, GA; Ali, JO; Gibbs, SR; Rahman, D; Taylor, GW; Wilkins, MR; Edwards, RJ (2006-04)

We have employed SELDI-TOF MS to screen for differentially expressed proteins in plasma samples from 27 patients with idiopathic pulmonary arterial hypertension (IPAH) and 26 healthy controls. One ion (m/z approximately ...

Chloride intracellular channel protein 4 (CLIC4) in the regulation of human pulmonary endothelial responses to hypoxia

Abdul Salam, V; Wilkins, MR; Wojciak-Stothard, B; British Thoracic Society WInter Meeting 2010 (2010-12-01)

Abstract S156 from British Thoracic Society Winter meeting 2010

RUBY-1: a randomized, double-blind, placebo-controlled trial of the safety and tolerability of the novel oral factor Xa inhibitor darexaban (YM150) following acute coronary syndrome

Steg, PG; Mehta, SR; Jukema, JW; Lip, GYH; Gibson, CM; Kovar, F; Kala, P; Garcia-Hernandez, A; Renfurm, RW; Granger, CB (2011-08-30)

Stepwise Optimization of the Procedure for Assessment of Circulating Progenitor Cells in Patients with Myocardial Infarction

Cui, Y-X; Johnson, T; Baumbach, A; Reeves, BC; Rogers, CA; Angelini, GD; Marsden, D; Madeddu, P (2012-01-17)

Chloride Intracellular Channel Protein-4 In The Vascular Dysfunction Of Pulmonary Arterial Hypertension

Salam, VBA; Lao, KH; Tsang, H; Zhao, L; Howard, LS; Wharton, J; Yuspa, SH; Wilkins, MR; Wojciak-Stothard, B (2012-05-01)

Abstract from American Thoracic Society 2012 International Conference, May 18-23, 2012 • San Francisco, California

Challenges in cardiac device innovation: is neuroimaging an appropriate endpoint? Consensus from the 2013 Yale-UCL Cardiac Device Innovation Summit

Meller, SM; Baumbach, A; Voros, S; Mullen, M; Lansky, AJ (2013)

Pre-hypertension: another 'pseudodisease'?

Meier, P; Messerli, FH; Baumbach, A; Lansky, AJ (2013)

Chloride intercellular channel-4 and vascular endothelial inflammatory responses associated with pulmonary arterial hypertension

Abdul Salam, V; Gierula, M; Edwards, RJ; Zhao, L; Wilkins, MR; Wojciak-Stothard, B; Sixth Annual Scientific Workshops and Debates of the Pulmonary Vascular Research Institute (PVRI) (Sage, 2013-09-01)

Abstract from Sixth Annual Scientific Workshops and Debates of the Pulmonary Vascular Research Institute (PVRI), Istanbul, January 21–25, 2013

Point of care platelet activity measurement in primary PCI [PINPOINT-PPCI]: a protocol paper

Johnson, TW; Marsden, D; Mumford, A; Pike, K; Mundell, S; Butler, M; Strange, JW; Bowles, R; Rogers, C; Baumbach, A (2014)

Imatinib inhibits VEGF-independent angiogenesis by targeting neuropilin 1-dependent ABL1 activation in endothelial cells

Raimondi, C; Fantin, A; Lampropoulou, A; Denti, L; Chikh, A; Ruhrberg, C (Rockefeller University Press, 2014-06-02)

A Study of Platelet Inhibition, Using a 'Point of Care' Platelet Function Test, following Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction [PINPOINT-PPCI].

Johnson, TW; Mumford, AD; Scott, LJ; Mundell, S; Butler, M; Strange, JW; Rogers, CA; Reeves, BC; Baumbach, A (2015)

BACKGROUND: Rapid coronary recanalization following ST-elevation myocardial infarction (STEMI) requires effective anti-platelet and anti-thrombotic therapies. This study tested the impact of door to end of procedure ...

A systematic approach to echocardiography in hypertrophic cardiomyopathy: a guideline protocol from the British Society of Echocardiography

Smith, N; Steeds, R; Masani, N; Sandoval, J; Wharton, G; Allen, J; Chambers, J; Jones, R; Lloyd, G; Rana, B (2015)

Percutaneous coronary intervention in the UK: recommendations for good practice 2015.

Banning, AP; Baumbach, A; Blackman, D; Curzen, N; Devadathan, S; Fraser, D; Ludman, P; Norell, M; Muir, D; Nolan, J (2015-05)

Over the last 35 years, there has been dramatic progress in the technology and applicability of percutaneous techniques to treat obstructive coronary heart disease. Percutaneous coronary intervention (PCI) has a considerable ...

Management of hypertensive patients with multiple drug intolerances: single-centre experience of a novel treatment algorithm

Saxena, M; Antoniou, S; Hamedi, N; de Cates, C; Moghul, S; Lidder, S; Kapil, V; Lobo, MD (2015-10)

Evaluation of biodegradable stent gratf coatings in preclinical setting

Taavitsainen, J; Hytonen, JP; Kuivanen, A; Tarvainen, S; Laitinen, JTT; Mangiardi, E; Guelcher, M; Mathur, A; Martin, J; Yla-Herttuala, S (2016)

Stem cell therapy for chronic ischaemic heart disease and congestive heart failure

Fisher, SA; Doree, C; Mathur, A; Taggart, DP; Martin-Rendon, E (Cochrane Collaboration, 2016)

Renal artery sympathetic denervation: observations from the UK experience

Sharp, ASP; Davies, JE; Lobo, MD; Bent, CL; Mark, PB; Burchell, AE; Thackray, SD; Martin, U; McKane, WS; Gerber, RT (2016-06)

VEGF165-induced vascular permeability requires NRP1 for ABL-mediated SRC family kinase activation.

Fantin, A; Lampropoulou, A; Senatore, V; Brash, JT; Prahst, C; Lange, CA; Liyanage, SE; Raimondi, C; Bainbridge, JW; Augustin, HG (2017-04-03)

The vascular endothelial growth factor (VEGF) isoform VEGF165 stimulates vascular growth and hyperpermeability. Whereas blood vessel growth is essential to sustain organ health, chronic hyperpermeability causes damaging ...

ANTIHYPERTENSIVE EFFECTS OF A CENTRAL ARTERIOVENOUS ANASTOMOSIS ARE MEDIATED THROUGH PROFOUND REDUCTION IN SYSTEMIC VASCULAR RESISTANCE

Saxena, M; Shour, T; Sobotka, P; Jain, A; Collier, DJ; Hamshere, S; Mathur, A; Knight, C; Lobo, MD (2017-09)

POSTERS’ SESSION PS24 Abstract PP.24.26

Letter to the editor - round table unites to tackle culture change in an effort to improve animal research reporting

Osborne, NJ; Ritskes-Hoitinga, M; Ahluwahlia, A; Alam, S; Brown, M; Henderson, H; de Leeuw, W; Marsh, J; Moher, D; van Oort, E (2017-11-07)